Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

EDITORIAL: Region 's hospitals needto collaborate to advance cancer screening, treatment  Join our daily free Newsletter

MENAFN - - 4/15/2012 5:22:39 AM

Digg This Article: http%3a%2f%2fwww.menafn.com%2fmenafn%2fqn_news_story.aspx%3fstoryid%3d%257B75be832b-e25a-464e-aebd-b6fdc02be1b7%257D Share This Article: http%3a%2f%2fwww.menafn.com%2fmenafn%2fqn_news_story.aspx%3fstoryid%3d%257B75be832b-e25a-464e-aebd-b6fdc02be1b7%257D Add to Delicious Seed this article Buzz this article Add to Reddit Add to furl Add to stumbleupon Add to Mixx!


EDITORIAL: Region 's hospitals needto collaborate to advance cancer screening, treatment

Apr 15, 2012 (Menafn - The Sacramento Bee - McClatchy-Tribune Information Services via COMTEX) --We are privileged in the Greater Sacramento region, a health care hub for much of Northern California, to have one of the nation's 44 comprehensive cancer centers. With that prestigious designation comes great opportunity -- and great responsibility.

With passage of the National Cancer Act of 1971, the United States made a commitment to greatly expand cancer research. National Cancer Institute-designated "comprehensive cancer centers" are the centerpiece of the nation's effort to fight cancer with science -- and the development of new techniques to prevent, detect, diagnose and treat cancer.

The entire medical community in our region should capitalize on the status of the newly renamed UC Davis Comprehensive Cancer Center, now in the top tier of cancer centers nationwide -- as the Boston area did in the late 1990s. There, a seven-member consortium brought together the resources of Harvard Medical School and area hospitals in the fight against cancer.

While the Boston consortium remains unique nationally, we in Sacramento can aim to build on unique strengths at the university to improve connections between our four major not-for-profit health plans involved in cancer -- UC Davis Health System, CHW/Mercy, Sutter Health and Kaiser Permanente.

A primary strength is the biomedical technology program, truly a unique national resource finding new technologies, instruments and methods for cancer screening, diagnosis and treatment. For example, researchers are studying markers for malignant cells and detection methods that don't involve invasive surgical procedures, even if cells are deep in tissue.

Another is the veterinary school, which allows for the study of cancer biology in animals. For example, cats and dogs, which live in the same environments as people, get cancer -- providing a good bridge toward clinical trials with people. The university also has a first-rate program working with mutations in mice.

The university's program to reduce disparities among different ethnic and income groups is a big plus in diverse California. Combined with the California Cancer Registry, one of the leading cancer registries in the world, the university is well-placed to make a significant contribution. For example, it is working with Asians who have liver cancer, studying the effect of secondhand smoke among Chinese and addressing lack of breast cancer screening among Native Americans.

Despite these advantages, our region's portfolio of clinical trials remains limited and the number of patients in trials continues to be relatively small. Conducting high-quality clinical trials is essential to test the effectiveness of new agents and technologies -- and getting them to doctors and patients. This is where formal cooperation across institutions in our region would help -- as it did in Boston.

Dr. Ralph deVere White, founder and director of the UC Davis Comprehensive Cancer Center, has suggested that a low-risk place to start in Sacramento might be to set up a citywide early Phase I clinical trial program, studying new techniques in their first phase of development, working with people whose cancers don't respond to the usual treatments. The region has few of these trials, so no one would have turf to protect.

Cooperation on this front would help leverage public and private funds. It would make it easier for each of the systems to get enough patients to make trials worthwhile -- no patient "grab" here in the stiff competition for patients. Each system would recruit its own patients and trials would occur at multiple sites. Cooperation would provide synergy in the regional scientific talent pool, and allow efficiencies in managing highly complex (and tightly regulated) trials.

Increasing the number and quality of clinical trials seems a promising way to go in Sacramento -- as the medical community did in Boston. Now is the time for the region to come together to use the university's "comprehensive cancer center" designation effectively to make a dent in the fight against cancer.

___ (c)2012 The Sacramento Bee (Sacramento, Calif.) Visit The Sacramento Bee
(Sacramento, Calif.) at www.sacbee.com Distributed by MCT Information Services


 






International Provider
May 21, 2013 Joint Industry Plan; Notice of Filing and Immediate Effectiveness of Amendment No. 29 to the Joint Self-Regulatory Organization Plan Governing the Collection, Consolidation and Dissemination of Quotation and Transaction Information for Nasdaq-Listed Securities Traded on Exchanges on an Unlisted Trading Privileges Basis Submitted by the BATS Exchange, Inc., BATS Y- Exchange, Inc., Chicago Board Options Exchange, Incorporated, Chicago Stock Exchange, Inc., EDGA Exchange, Inc., EDGX Exchange, Inc., Financial Industry Regulatory Authority, Inc., International Securities Exchange LLC, NASDAQ OMX BX, Inc., NASDAQ OMX PHLX LLC, Nasdaq Stock Market LLC, National Stock Exchange, Inc., New York Stock Exchange LLC, NYSE MKT LLC, and NYSE Arca, Inc., Federal Register
May 21, 2013 Small changes add up, McClatchy-Tribune Information Services -- Unrestricted
May 21, 2013 Minnesota iron ore will supply new North Dakota iron plant, McClatchy-Tribune Information Services -- Unrestricted
May 21, 2013 Before Administrative Judges: Ronald M. Spritzer, Chairman, Dr. Anthony J. Baratta, Dr. Randall J. Charbeneau; In the Matter of Detroit Edison Company (Fermi Nuclear Power Plant, Unit 3); Notice of Hearing (Notice of Evidentiary Hearing and Opportunity To Provide Oral and Written Limited Appearance Statements), Federal Register
May 21, 2013 Covanta to Exhibit at WasteExpo Booth #4875, Marketwire
May 21, 2013 WPCS Receives $4.1 Million in New Contracts, Marketwire
May 21, 2013 PowerSecure International buys Port lighting company, McClatchy-Tribune Information Services -- Unrestricted
May 21, 2013 DJ Raw Sugar Retreats Further Ahead of Brazilian Supplies, DowJones
May 21, 2013 London Evening Standard, Anthony Hilton column, McClatchy-Tribune Information Services -- Unrestricted
May 21, 2013 IIROC Trading Resumption - ZEN, CNW Group
more...


 
MENAFN






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help